Showing 1321-1330 of 1692 results for "".
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/30976/Combination Therapy in Alzheimer’s Disease: Long-Term Safety and EfficacyRecent advancements in Alzheimer's disease (AD) treatment highlight the potential benefits of combination therapy using cholinesterase inhibitors (CIs) and memantine (MEM). A pivotal study conducted by Dr. Alireza Atri and coll
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31156/Optimizing Alzheimer’s Disease Management: When and How to Integrate Memantine with Cholinesterase InhibitorsIn the evolving landscape of Alzheimer’s disease (AD) treatment, combining memantine with cholinesterase inhibitors has emerged as a pivotal strategy for managing moderate to severe stages of
- Keeping Tysabri Therapy on Targethttps://practicalneurology.com/columns/practice-management/keeping-tysabri-therapy-on-target/31170/Natalizumab (Tysabri) in Multiple Sclerosis: Balancing Efficacy and SafetyOne year following its reintroduction to the market, natalizumab (Tysabri) continues to be a focal point for multiple sclerosis (MS) specialists striving to optimize its use while mitigating associated risks. Originally withdr
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0307PainMngmt-pdf/31207/Exploring Botulinum Toxin Therapy for Neuropathic Pain ManagementNeuropathic pain, characterized by pain resulting from peripheral or central nervous system injury or dysfunction, includes conditions such as painful diabetic polyneuropathy, post-herpetic neuralgia (PHN), complex regional pain syndro
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31273/Recent advancements and studies in neurology offer promising insights for clinical practice. A GlaxoSmithKline-sponsored trial compared the efficacy of lamotrigine versus topiramate in 192 epilepsy patients. Results demonstrated that lamotrigine outperformed topiramate on cognitive assessments such
- The Tug-of-War Over Medical Liability Reformhttps://practicalneurology.com/columns/practice-management/the-tug-of-war-over-medical-liability-reform/31279/The ongoing struggle over medical liability reform in the United States remains a critical issue for healthcare professionals, particularly within the field of neurology. Physicians across various specialties face increasing malpractice insurance premiums and the pressures of defensive medicine, dri
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31300/Effective budgeting is a cornerstone of successful medical practices, including those in neurology, as highlighted by Craig T. Williams in the June 2006 issue of Practical Neurology. Williams emphasizes that creating, managing, and adhering to a realistic budget is essential for mitigating risks suc
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0506dementia-pdf/31311/In the May 2006 issue of *Practical Neurology*, Dr. David S. Geldmacher explores the enduring impact of the iconic TV character Dr. Marcus Welby on modern medical practice, particularly in the realm of dementia care. Dr. Welby symbolized the epitome of physician excellence—competent, compassionate,
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31314/Persistent Cognitive Deficits Post-Motor Vehicle Accident: A Case Study and Insights on Malingering in Neurological PracticeA 35-year-old male, Mr. M., presented five months after sustaining a whiplash injury from a motor vehicle accident. Initially treated by his chiropractor, Dr. J., Mr. M. contin
- Will You Be the Last Physician on Your Block to Offer Botox?https://practicalneurology.com/columns/practice-management/will-you-be-the-last-physician-on-your-block-to-offer-botox/31384/Botox’s Expanding Role in Neurology: A Future for Headache ManagementBotox, traditionally renowned for its cosmetic applications, is increasingly becoming integral to neurological practices, particularly in headache and migraine management. As of October 2005, Practical Neurology highlighted Botox’s